Patent details

EP2247282 Title: SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS

Basic Information

Publication number:
EP2247282
PCT Application Number:
PCT/EP/2009/051026
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097054548
PCT Publication Number:
WO/2009/095450
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS
French Title of Invention:
PRÉPARATION À LIBÉRATION SOUTENUE COMPRENANT DE L'OCTRÉOTIDE ET TROIS POLYMÈRES LINÉAIRES POLYLACTIDE-CO-GLYCOLIDE
German Title of Invention:
VERZÖGERT FREIGESETZTE FORMULIERUNG MIT OCTREOTID UND DREI LINEAREN POLYACTID-CO-GLYCOLID-POLYMEREN
SPC Number:

Dates

Filing date:
29/01/2009
Grant date:
20/08/2014
EP Publication Date:
20/08/2014
PCT Publication Date:
06/08/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/11/2010
EP B1 Publication Date:
20/08/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/01/2015
Expiration date:
29/01/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/01/2009
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
AHLHEIM Markus
Address:
Germany (DE)

2

Name:
PETERSEN Holger
Address:
Germany (DE)

Priority

Priority Number:
08150826
Priority Date:
30/01/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 9/00;
Filing date Document type Number of pages